[HTML][HTML] Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and …
CC Lai, YH Liu, CY Wang, YH Wang, SC Hsueh… - Journal of Microbiology …, 2020 - Elsevier
Since the emergence of coronavirus disease 2019 (COVID-19)(formerly known as the 2019
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
S Cambier, M Gouwy, P Proost - Cellular & Molecular Immunology, 2023 - nature.com
Chemokines are an indispensable component of our immune system through the regulation
of directional migration and activation of leukocytes. CXCL8 is the most potent human …
of directional migration and activation of leukocytes. CXCL8 is the most potent human …
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma… - Nature medicine, 2021 - nature.com
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …
COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
J Carvelli, O Demaria, F Vély, L Batista… - Nature, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a disease caused by infection with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in a pandemic …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in a pandemic …
[HTML][HTML] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
COVID-19 and sex differences: mechanisms and biomarkers
Men are consistently overrepresented in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …
Laboratory findings in COVID-19 diagnosis and prognosis
A Pourbagheri-Sigaroodi, D Bashash, F Fateh… - Clinica chimica acta, 2020 - Elsevier
Background Since its first description, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), formerly known as 2019-nCoV, has attracted tremendous attention in a short …
(SARS-CoV-2), formerly known as 2019-nCoV, has attracted tremendous attention in a short …
Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread to become a
worldwide emergency. Early identification of patients at risk of progression may facilitate …
worldwide emergency. Early identification of patients at risk of progression may facilitate …
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis
X Li, C Liu, Z Mao, M **ao, L Wang, S Qi, F Zhou - Critical Care, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19), a highly infectious disease,
has been rapidly spreading all over the world and remains a great threat to global public …
has been rapidly spreading all over the world and remains a great threat to global public …